iRhythm Technologies Future Growth
Future criteria checks 4/6
iRhythm Technologies is forecast to grow earnings and revenue by 77.9% and 14.7% per annum respectively. EPS is expected to grow by 79.7% per annum. Return on equity is forecast to be -3.9% in 3 years.
Key information
77.9%
Earnings growth rate
79.70%
EPS growth rate
Medical Equipment earnings growth | 13.0% |
Revenue growth rate | 14.7% |
Future return on equity | -3.89% |
Analyst coverage | Good |
Last updated | 21 Aug 2025 |
Recent future growth updates
Recent updates
iRhythm Technologies, Inc. (NASDAQ:IRTC) Just Reported And Analysts Have Been Lifting Their Price Targets
Aug 04Would iRhythm Technologies (NASDAQ:IRTC) Be Better Off With Less Debt?
Jul 21iRhythm: Promising Outlook - So Long As Past Mistakes Are Not Repeated
Jun 12
Ambulatory Monitoring And Digital Health Will Transform Global Markets
Accelerated global adoption of Zio and digital health integration is expanding iRhythm's market reach, operational efficiency, and recurring revenue streams.iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Share Price Matching Investor Opinion
Apr 24Would iRhythm Technologies (NASDAQ:IRTC) Be Better Off With Less Debt?
Apr 03A Look At The Fair Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC)
Feb 15Is It Too Late To Consider Buying iRhythm Technologies, Inc. (NASDAQ:IRTC)?
Jan 31What You Can Learn From iRhythm Technologies, Inc.'s (NASDAQ:IRTC) P/S
Jan 16iRhythm Technologies: Today's 510(K) Victory May Only Be A Temporary Reprieve
Oct 22Take Care Before Jumping Onto iRhythm Technologies, Inc. (NASDAQ:IRTC) Even Though It's 26% Cheaper
Oct 13Is iRhythm Technologies (NASDAQ:IRTC) A Risky Investment?
Sep 19Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2027 | 979 | 41 | 112 | 158 | 10 |
12/31/2026 | 847 | -18 | 68 | 114 | 14 |
12/31/2025 | 726 | -54 | 10 | 43 | 14 |
6/30/2025 | 657 | -92 | 13 | 63 | N/A |
3/31/2025 | 619 | -98 | -1 | 48 | N/A |
12/31/2024 | 592 | -113 | -46 | 3 | N/A |
9/30/2024 | 560 | -151 | -87 | -32 | N/A |
6/30/2024 | 537 | -132 | -96 | -55 | N/A |
3/31/2024 | 513 | -130 | -113 | -71 | N/A |
12/31/2023 | 493 | -123 | -91 | -50 | N/A |
9/30/2023 | 473 | -105 | -56 | -22 | N/A |
6/30/2023 | 452 | -99 | -50 | -19 | N/A |
3/31/2023 | 430 | -105 | -48 | -15 | N/A |
12/31/2022 | 411 | -116 | -53 | -23 | N/A |
9/30/2022 | 380 | -128 | -76 | -49 | N/A |
6/30/2022 | 362 | -131 | -69 | -35 | N/A |
3/31/2022 | 341 | -124 | -64 | -35 | N/A |
12/31/2021 | 323 | -101 | -66 | -38 | N/A |
9/30/2021 | 320 | -79 | -43 | -17 | N/A |
6/30/2021 | 306 | -59 | -42 | -24 | N/A |
3/31/2021 | 276 | -63 | -48 | -33 | N/A |
12/31/2020 | 265 | -44 | -27 | -14 | N/A |
9/30/2020 | 245 | -51 | -49 | -26 | N/A |
6/30/2020 | 228 | -65 | -59 | -38 | N/A |
3/31/2020 | 230 | -55 | -49 | -27 | N/A |
12/31/2019 | 215 | -55 | -42 | -22 | N/A |
9/30/2019 | 197 | -54 | -32 | -21 | N/A |
6/30/2019 | 181 | -45 | -34 | -26 | N/A |
3/31/2019 | 165 | -48 | N/A | -33 | N/A |
12/31/2018 | 147 | -50 | N/A | -29 | N/A |
9/30/2018 | 134 | -45 | N/A | -28 | N/A |
6/30/2018 | 120 | -42 | N/A | -27 | N/A |
3/31/2018 | 108 | -35 | N/A | -22 | N/A |
12/31/2017 | 99 | -30 | N/A | -15 | N/A |
9/30/2017 | 89 | -25 | N/A | -12 | N/A |
6/30/2017 | 81 | -22 | N/A | -11 | N/A |
3/31/2017 | 73 | -20 | N/A | -14 | N/A |
12/31/2016 | 64 | -21 | N/A | -17 | N/A |
9/30/2016 | 56 | -22 | N/A | -21 | N/A |
6/30/2016 | 49 | -24 | N/A | -24 | N/A |
3/31/2016 | 41 | -24 | N/A | -24 | N/A |
12/31/2015 | 36 | -23 | N/A | -18 | N/A |
9/30/2015 | 32 | -19 | N/A | -17 | N/A |
12/31/2014 | 22 | -16 | N/A | -16 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IRTC is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (3.1%).
Earnings vs Market: IRTC is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: IRTC is expected to become profitable in the next 3 years.
Revenue vs Market: IRTC's revenue (14.7% per year) is forecast to grow faster than the US market (9.3% per year).
High Growth Revenue: IRTC's revenue (14.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: IRTC is forecast to be unprofitable in 3 years.
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/08/24 02:19 |
End of Day Share Price | 2025/08/22 00:00 |
Earnings | 2025/06/30 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
iRhythm Technologies, Inc. is covered by 26 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
David Rescott | Baird |
Michael Polark | Baird |
Joanne Wuensch | BMO Capital Markets Equity Research |